from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2488c/-

LFCtreatmentdescriptionclass of inhibitor

-0.227

Amikacinug/mL Amikacintranslation

0.012

Cap5-10ug/mL Capreomycintranslation

0.153

Rox10-50 ug/mL Roxithromycintranslation

-0.039

SM2-5 ug/mL Streptomycintranslation

-0.542

Tet5-10 ug/mL Tetracyclinetranslation

-0.423

Rif0.2-5ug/mL Rifampicintranscription

0.202

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.404

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.351

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.124

CPZ10-50 ug/mL Chlorpromazinerespiration

0.856

Clofazimine10-13 ug/mL Clofaziminerespiration

0.395

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.579

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.823

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.526

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.680

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.325

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.541

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.529

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.028

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.149

KCN5-20 ug/mL Potassium cyaniderespiration

0.910

NaN30.2-2 mM Sodium aziderespiration

0.641

Nigericin50 uM Nigericinrespiration

-0.527

TRC10-150 ug/mL Triclosanrespiration

-0.315

TRZ10-25 ug/mL Thioridazinerespiration

-1.011

Valinomycin0.5-10 uM Valinomycinrespiration

0.402

ZnSO42 mM ZnSO4respiration

-0.381

menadione6-10 ug/mL Menadionerespiration

0.047

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.479

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.128

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.493

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.390

NRP_1Non-replicating persistence stage 1dosRassociated

-0.176

Amp0.2mg/mL AmpicillincellWall

0.142

Cephalexin20-100 ug/mL CephalexincellWall

0.141

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.100

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.205

EMB10-20 ug/mL EthambutolcellWall

0.590

Eta12-40 ug/mL EthionamidecellWall

0.945

INH0.2-0.4 ug/mL IsoniazidcellWall

0.960

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.371

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.412

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.167

BZA0.12 mg/mL BenzamidearomaticAmides

0.126

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.467

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.337

H2O24 mM hydrogen peroxideDNAdamaging

0.210

Levo10 ug/mL LevofloxacinDNAdamaging

-0.211

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.280

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.483

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.304

UVUV-irradiationDNAdamaging

-0.035

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.598

Antimycin12.5-50 ug/mL Antimycin A?

0.267

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.209

PA_110-50 ug/mL Antitubercular compound PA-1?

0.024

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.331

PA8240.2-2 ug/mL PA-824?

-0.437

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.343

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.398

Verapamil50 uM Verapamil?

0.179

mercaptoethanol2 mM 2-Mercaptoethanol?

0.444

methoxatin10-20 ug/mL Methoxatin?